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Abstract 
Background: The present study was conducted to evaluate the effect of 
Lidocaine on pain reduction during and ileus and the need for opioids after 
caesarean section.  
Materials and Methods: This study was randomized double-blind 
controlled clinical trial. 40 ASA I, II pregnant women were candidates for 
caesarean section with general anesthesia. They were randomly allocated into 
two groups of Lidocaine receivers and placebo using randomized block 
design; the Lidocaine group received 1.5 mg/kg of Lidocaine right before the 
surgery and then its infusion with a dose of 2 mg/Kg/h until the end of the 
surgery and the placebo group received normal saline with the same volume 
and application. Patients’ pain intensity was measured using numerical rating 
scale (NRS), 0 (entering the recovery), 0.5, 1, 4, 12 and 24 hours after the 
surgery.   
Results: Lidocaine decreased the systolic and diastolic pressures of the 
patients only during the first minute after intubation. There was decrease in 
mean of arterial blood pressure at the 10th minute after intubation and 40th 
minute after surgery. In addition, decreased the mean of patients’ pain 
intensity, Diclofenac and Pethidine consumption, side effects (nausea and 
vomiting), and reduced the time interval before the first time of tolerating 
oral liquids; but it had effect on infants’ Apgar score 1 and 5 minutes after 
delivery.  
Conclusion: Lidocaine was definitely effective on reducing the intensity of 
pain, opioid and non-steroidal anti-inflammatory drugs consumption and ileus 
after surgery with the least occurrence of side effects for mothers and infants.  
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Introduction 
One of the most common complications of 
caesarean section is postoperative pain (1). Also the 
most common and important cause of dissatisfaction 
among mothers who has been under caesarean section 
at health centers is postoperative pain (1). Pain, 
during the first days after delivery, is an important 
obstacle for taking care of the infant and 
breastfeeding; therefore specialists’ attention for 
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controlling postoperative pain is necessary (1, 2). 
Proper management of postoperative pain has 
been of great importance during the recent years. The 
intensity of postoperative pain depends on various 
factors like patient’s perception of pain and threshold, 
the type and duration of surgery, the type of 
anesthesia and used anesthetics and patient’s mental 
and psychological condition (example: differences in 
mental condition in laparotomy for caesarean section 
against laparotomy for uterus cancer) (1, 3). 
The important matter in controlling 
postoperative pain after caesarean section is reducing 
morbidity and mother’s faster recovery for returning 
home (4). There are different methods for getting 
mothers back to the desirable condition for taking 
care of their infant, breastfeeding, and pain 
management after caesarean. Like systemic analgesia 
methods and regional analgesia methods (constant 
infusion or injecting a dose of analgesic drug to the 
site of surgery), which would be used after evaluating 
their complications and advantages and patient’s 
condition (1, 2).  
In many Iranian health centers, which is a 
developing country, the rate of caesarean section is 
higher than the standard rate (30% of all the 
deliveries) and this would make it impossible to 
provide pain control strategies for all the patients (4). 
Using non-steroidal anti-inflammatory drugs 
and opioids is the traditional and most common 
method for controlling post-operative pain. However 
there are also some regional analgesic methods which 
are more powerful than opioid drugs. Also, using 
narcotic injections compared to regional methods is 
associated with side effects such as nausea, vomiting, 
respiratory distress, constipation and dizziness (1, 2). 
Modern methods such as constant epidural infusion or 
patient controlled analgesia (PCA), besides needing 
trained personnel and special facilities, are expensive 
and associated with some side effects (spinal 
hematoma). On the other hand, due to low cultural 
and educational level of the patients who refer to most 
of the health centers, it is not possible to use advanced 
pain management devices patient controlled analgesia 
pumps or PCA (1, 2, 4, 5). Another study has 
evaluated the effect of using oral painkillers like 
Dipyrone and Morphine right after delivery (1, 2, 5, 
6). 
One of the commonly used analgesic drug in 
this field is Lidocaine which is used as an 
antiarrhythmic IB class drug for treating ventricular 
tachycardia and sometimes myocardial ischemia. This 
drug has analgesic and anti-hyperalgesia effects (7). 
Lidocaine is not teratogenic and it is a safe drug in its 
therapeutic doses and, except for neonatal inter-scalp 
injections that could cause neonatal toxicity, it has 
few side effects. Lidocaine has a low excretion into 
breast milk and its half-life is 90 to 120 minutes. 
Using Lidocaine during early pregnancy would not 
increase the risk for embryonic defects but it would 
decrease the blood supply for the placenta and 
increase the uterine myometrium tone. In high dose 
injections, it would temporarily and transiently 
decrease the Apgar score of infants (1, 5, 6). 
Furthermore, Lidocaine is an inexpensive, easily 
injectable and relatively safe drug (7). 
The mechanisms of anesthetic drugs are 
numerous. The anesthetic effect of drugs, when 
prescribed before trauma to the tissue, is based on the 
preventive theory of central pain sensitization. 
Prescribing anesthetics before trauma would linger 
the pharmacokinetic effects of the anesthetic method 
(1). 
Therefore the anesthetic drug would be 
administered through different methods of 
intramuscular, intravenous, epidural, regional 
peripheral nerve block, slowly intraperitoneal 
injection or subcutaneous injection (8, 9). The effect 
of Lidocaine on pain reduction in surgeries has 
previously been studied. In a study, local injection of 
Lidocaine before making the incision in caesarean 
section led to pain reduction during the early hours 
after the surgery in mothers without any side effects; 
it also reduced the need for opioids. Also injecting IM 
injection, SC injection or both of Lidocaine after 
making the incision in caesarean section into rectus 
abdominus muscle would reduce post-operative pain 
and the duration of hospitalization (6). 
Therefore, considering the importance of pain 
control after caesarean section, preventive use of 
analgesic agents during surgery could be reasonable 
for reducing post-operative pain (7). Considering the 
advantages of local injection methods and the 
appropriateness of lidocaine for this matter, this study 
evaluated the effect of intravenous injection of 
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Lidocaine during caesarean section with general 
anesthesia on pain, ileus and the need for opioids after 
surgery. 
Methods 
This study was a randomized controlled 
double-blind clinical trial which was conducted from 
winter 2015 to autumn 2015 at Al-Zahra and Beheshti 
hospitals after taking permission from ethics 
committee of Isfahan University of Medical Sciences. 
ASA I and II term pregnant women (more than 37 
weeks), who were candidates for caesarean section 
with general anesthesia were enrolled in the study. 
The exclusion criteria were: receiving 
antiarrhythmic drugs, having any previous diagnosed 
allergy to Lidocaine, having diabetes, having 
neurologic problems, being an addict, chronic use of 
opioids or analgesics, having any type of heart blocks, 
having any type of arrhythmia, having a history of 
myopathy, having renal or hepatic problem or a GFR 
< 40% and having a heart problem or EF<45%. 
Surgeries that lasted more than 2 hours, were 
associated with complications such as bladder injury 
which required urology intervention, hysterectomy, 
blood transfusion (due to major bleeding) which led 
to acid-base disorders and diagnosed or pregnancy-
related treatment-resistant hypotension, were also led 
to patient’s exclusion. Participants were allocated into 
two groups of Lidocaine receivers and placebo 
(normal saline) through block random allocation 
The drug and the placebo were prepared and 
coded in similar syringes by an anesthesia technician. 
The person who injected the syringes was different 
from the one who prepared them. The Lidocaine 
group received 1.5 mg/kg of Lidocaine right before 
the surgery and its infusion with a dose of 2 mg/kg.h 
lasted from clamping the umbilical cord and taking 
out the neonate until the end of the surgery and 
putting the bandages. 
Patients of the placebo group received similar 
doses of normal saline. Then necessary measures for 
general anesthesia and then transfer to the recovery 
room were performed. Patients were monitored for 
ECG, SPO2 and NIBP from the beginning and all of 
the vital signs of the patients were measured and 
recorded before the induction, before intubation, 1, 5 
and 10 minutes after intubation and then every half an 
hour until the end of the surgery. Also, after the 
surgery and the infusion ended, patients’ vital signs 
were recorded every 15 minutes at the recovery room. 
Patients’ pain intensity at 0, 0.5, 1, 4, 12 and 24 
hours after the surgery were measured and recorded. 
Pain’s scoring was based on numerical rating 
scale (NRS) and the scales were no pain (0), mild (1-
4), moderate (5-7) and severe (8-10); an NRS of 4 or 
more required intervention and treatment. Treatment 
was first started by prescribing Diclofenac 100 mg 
suppository and in case the pain did not stop, 50 mg 
of Pethidine was injected intravenously.  
After being transferred to the ward, patients 
who received standard treatment with Diclofenac and 
Pethidine, based on their own request and NSR of 4 
or more, received another suppository of Diclofenac 
and if needed, 50 mg of IM Pethidine. The time of 
entering the recovery room and the time for the first 
request for pain killers at the recovery room and the 
ward were recorded. The extra doses of Diclofenac 
and Pethidine were also measured and recorded. 
Regarding sedation, patients were categorized into 4 
groups of 0 = alert, I = sleepy but arousable, II = 
stupor and III = coma. 
Side effects after surgery including 
lightheadedness, numbness and tingling in the 
extremities, nausea, vomiting and severe drowsiness 
were recorded. The duration of anesthesia, from the 
time of induction of anesthesia until transferring to 
the recovery room was calculated and recorded.  
The duration of extubation, from the time of 
cutting the anesthetic until removing the tracheal tube 
was calculated and recorded. If the patient had 
hypotension of SBP < 90 mmHg or less than 20% of 
the baseline pressure drop, 5 mg of Ephedrine was 
injected intravenously. In case of Bradycardia (HR < 
50), 0.5 mg Atropine was prescribed. 
The duration of staying in the recovery room 
was measured and recorded from the time of entering 
until the time of being discharged from the recovery 
room based on modified aldreet score. Infant’s Apgar 
score was measured and recorded 1 and 5 minutes 
after birth. The sample size was estimated to be 20 for 
each group with a confidence interval of 95%, test 
power of 0.84 and accuracy of 0.5. Data were 
analyzed using SPSS 21 (Chicago, Illinois, USA). A p 
value of less 0.05 was considered significant. For 
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analyzing qualitative data, t test and chi-square were 
used. Mann-Whitney test was used for analyzing 
categorical variables. Variance analysis with repeated 
measures, Newman-Kelus test and post hoc student 
tests were used for analyzing hemodynamic variables 
at different times in both groups. 
Results 
Forty pregnant women were enrolled as the 
participants for this study. Demographic 
characteristics and the duration of surgery and 
recovery are respectively presented in tables 1 and 2. 
The mean changes of systolic and diastolic 
blood pressure had a significant difference between 
both groups only one minute after intubation (p< 
0.05) (Figure 1, 2). 
The mean of changes in the arterial blood 
pressure of patients, at the same time intervals, had a 
significant difference between both groups 10 and 40 
minutes after the surgery (p< 0.05) (Figure 3). 
The mean of changes in the patients’ heart rate, 
at the same time intervals, had a significant difference 
between both groups 1 minute after intubation (p< 
0.05) (Figure 4). 
The mean of changes in patients’ oxygen 
saturation, at the same time intervals, had a significant 
difference between both groups 40 minutes after the 
surgery (p< 0.05) (Figure 5). 
The mean of changes in patients’ blood 
pressure, heart rate and oxygen saturation are shown 
in diagrams 1 to 5.  























































































































































The mean of patients’ intensity of pain based 
on NRS at the time of entering the recovery room, 15 
minutes into the recovery room and then 4, 12, and 24 
hours after the surgery had a significant difference 
between both groups (p < 0.05). No significant 
difference was observed between both groups at any 
other measurement time (p > 0.05) (Figure 6). 
The mean of consuming extra doses of 
Diclofenac suppository, at the moment of entering the 
recovery room, 15 and 60 minutes into the recovery 
 
Figure 1.  The linear diagram of the mean of systolic 
blood pressure for each studied group separately 
(mmHg). 
 
Figure 2.  The linear diagram of the mean of diastolic 
blood pressure for each studied group separately 
(mmHg). 
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and 4 and 12 hours after the surgery was significantly 
lower in the Lidocaine receiving group compared to 
the placebo group; their difference was significant (p 
< 0.05). Considering the injection of extra doses of 
Pethidine, at the moment of entering the recovery 
room and 15 minutes into the recovery room and also 
4 hours after the surgery, it was lower in the 
Lidocaine receiving group compared to the placebo 
group and their difference was significant (p < 0.05) 
(Figures 7 and 8). 
The level of drowsiness at all the measurement 
times had no significant difference between both 
groups (p > 0.05) (Figures 9, 10, 11). 
The frequency of the incidence of nausea and 
vomiting had a significant difference between both 
groups (p< 0.05) (Figure 12). 
The frequency of the incidence of side effects 
had no significant difference between both groups (p> 
0.05) (Figure 13). 
The mean of Apgar score of infants one and 
five minutes after birth showed no significant 
difference between both studied groups (p>0.05). 
Discussion 
The present study revealed that intravenous 
bolus injection of Lidocaine during surgery would 
decrease systolic and diastolic blood pressure and 
heart rate during the first minute after laryngoscopy 
and endotracheal intubation. However, according to 
previous studies, which had not used (10-12) this 
drug, could be effective on hemodynamic stability of 
pregnant women during laryngoscopy and 
endotracheal intubation. Furthermore, pain intensity 
and consumption of extra doses of analgesic drugs 
were lower in the Lidocaine receiving group 
compared to the placebo group.  
The effect of local application of Lidocaine for 
pain reduction during surgeries has been previous 
studied. In one study, local injection of Lidocaine 
before making the incision in caesarean section, with 
no side effects for the mother, decreased the pain 
during the first hours after surgery and also decreased 
the need for opioids. Also subcutaneous injection of 
Lidocaine or intramuscular injection into rectus 
abdominis or both after making the incision in 
caesarean section would decrease post-operative pain 
intensity and duration of hospitalization (1, 6, 13). 
Intravenous injection during and after abdominal 
surgeries in different studies (14), would decrease the 
duration of hospitalization and would also decrease 
ileus, as the most important factor in lingered 
hospitalizations. Also patients would experience less  
 
Figure 3.  The linear diagram of the mean of arterial 
blood pressure for each studied group separately 
(mmHg). 
 
Figure 4.  The linear diagram of patients’ heart rate 
for each studied group separately. 
 
Figure 5.  The linear diagram of patients’ oxygen 
saturation for each studied group separately. 
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nausea and vomiting during the first 24 hours after 
surgery and would need less Morphine (15, 16). The 
present study also approved the reduction of nausea 
and vomiting and less consumption of opioids. 
Intravenous injection of Lidocaine in radical 
prostatectomy, along with similar effects, was also 
effective in return of bowel functions (17). 
Intravenous injection of Lidocaine would decrease the 
intensity of permanent pain in women after breast 
surgeries (18).  
Lidocaine had similar analgesic effects after 
cholecystectomy surgeries and laparoscopic 
cholecystectomy; it led to a decrease in the need for 
opioids, faster resolve of ileus and sooner discharges 
of the patient from the hospital (7, 19, 20). The 
present study also approved the safe and 
uncomplicated analgesic and hyper analgesic effect of 
Lidocaine 21) in pregnant women who were 
candidates for caesarean section. One of the 
limitations of this study was not measuring the serum 
level of Lidocaine, but considering all the conducted 
monitoring and patients’ vital signs, no toxicity was 
Table 2: Comparing the mean duration of surgery and recovery between both groups. 
Variable Lidocaine receiving group Placebo group P value 
Duration of surgery 
(minutes) 
59.75 ± 18.3 51.5 ± 10.2 P ≥ 0.05 
Duration of recovery 60 ± 0.0 60 ± 0.0 P > 0.05 
 
 P values less than 0.05 indicate statistically significant difference 
 
Table 1: Frequency distribution and dispersion of demographic characteristics for each group. 
 
Variable Lidocaine receiving group Placebo group P value 
Age (years) 29.3 ± 3.3 29.3 ± 4.6 0.938 
Gestational age (weeks) 39.9 ± 0.5 38.4 ± 1.1 0.066 
Height (cm) 160 ± 4.8 161.5 ± 6.4 0.408 
Weight (kg) 80.9 ± 12 79.75 ± 10.4 0.749 
Body Mass Index (BMI) 31.59 ± 4.4 30.49 ± 2.8 0.345 
 Variables are presented as mean ± SD 
 P values less than 0.05 indicate statistically significant difference 
 
 
Figure 6.  The linear diagram of patients’ intensity of 
pain based on intensity. 
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observed with this drug and the applied dosage. But 
conducting further studies with larger sample size and 
measurement of the serum level of Lidocaine is 
recommended. Another limitation of this study was 
not measuring the chronic pain of the patients after 
caesarean section. Since, the helpful effect of 
Lidocaine in controlling chronic pain after surgeries 
(18, 22, 23) has been approved, future studies could 
assess this matter; because in the present study 
patients could only be observed for 24 hours after the 
surgery. Therefore prescribing Lidocaine during the 
induction and also during the caesarean section, with 
no adverse effect on mothers’ hemodynamics during 
the surgery or infants’ Apgar score, could decrease 
the intensity of pain and also nausea and vomiting 
after surgery. It could also lead to a significant 
reduction in the use of opioids and pain killers after 
surgery and ileus (in case of any). Since this drug has 
a suitable price and could be applied easily, it could 
be afforded for being used during caesarean sections. 
 
 
Figures 7 & 8.  The frequency histogram for consuming Diclofenac suppository & Pethidine in each group separately. 
 
Figure 9.  The frequency histogram for the level of 
drowsiness in both groups at the time of entering the 
recovery room. 
 
Figure 10.  The frequency histogram for the level of 
drowsiness in both groups 30 minutes into the recovery 
room. 
 
Figure 11.  The frequency histogram for the level of 
drowsiness in both groups 60 minutes into the recovery 
room. 
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Conclusion 
Using systemic Lidocaine during surgery with 
a bolus dose of 1.5 mg/kg and infusion dose of 2 
mg/kg/h during caesarean section with general 
anesthesia, along with the hemodynamic stability of 
the mother after laryngoscopy and endotracheal 
intubation, could significantly decrease the intensity 
of post-operative pain, consumption of opioids and 
non-steroidal anti-inflammatory drugs and also ileus 
after the surgery. 
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